2013-2028 Report on Global Hemophilia Gene Therapy Market by Player, Region, Type, Application and Sales Channel


Report ID : RC-50881 Category : Medical Devices
Published Date : Oct-19 Pages : 108 Format : PDF
The global Hemophilia Gene Therapy market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for Hemophilia Gene Therapy from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Hemophilia Gene Therapy market.

Leading players of Hemophilia Gene Therapy including:
    Spark Therapeutics
    Ultragenyx
    Shire PLC
    Sangamo Therapeutics
    Bioverativ
    BioMarin
    uniQure
    Freeline Therapeutics

Market split by Type, can be divided into:
    Hemophilia A
    Hemophilia B

Market split by Application, can be divided into:
    Hemophilia A Gene Therapy
    Hemophilia B Gene Therapy

Market split by Sales Channel, can be divided into:
    Direct Channel
    Distribution Channel

Market segment by Region/Country including:
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Spain etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
    South America Brazil, Argentina, Colombia and Chile etc.)
    Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

Table of Contents

Chapter 1 Hemophilia Gene Therapy Market Overview
    1.1 Hemophilia Gene Therapy Definition
    1.2 Global Hemophilia Gene Therapy Market Size Status and Outlook (2013-2028)
    1.3 Global Hemophilia Gene Therapy Market Size Comparison by Region (2013-2028)
    1.4 Global Hemophilia Gene Therapy Market Size Comparison by Type (2013-2028)
    1.5 Global Hemophilia Gene Therapy Market Size Comparison by Application (2013-2028)
    1.6 Global Hemophilia Gene Therapy Market Size Comparison by Sales Channel (2013-2028)
    1.7 Hemophilia Gene Therapy Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Hemophilia Gene Therapy Market Segment Analysis by Player
    2.1 Global Hemophilia Gene Therapy Sales and Market Share by Player (2016-2018)
    2.2 Global Hemophilia Gene Therapy Revenue and Market Share by Player (2016-2018)
    2.3 Global Hemophilia Gene Therapy Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player
Chapter 3 Hemophilia Gene Therapy Market Segment Analysis by Type
    3.1 Global Hemophilia Gene Therapy Market by Type
        3.1.1 Hemophilia A
        3.1.2 Hemophilia B
    3.2 Global Hemophilia Gene Therapy Sales and Market Share by Type (2013-2018)
    3.3 Global Hemophilia Gene Therapy Revenue and Market Share by Type (2013-2018)
    3.4 Global Hemophilia Gene Therapy Average Price by Type (2013-2018)
    3.5 Leading Players of Hemophilia Gene Therapy by Type in 2018
    3.6 Conclusion of Segment by Type
Chapter 4 Hemophilia Gene Therapy Market Segment Analysis by Application
    4.1 Global Hemophilia Gene Therapy Market by Application
        4.1.1 Hemophilia A Gene Therapy
        4.1.2 Hemophilia B Gene Therapy
    4.2 Global Hemophilia Gene Therapy Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Hemophilia Gene Therapy by Application in 2018
    4.4 Conclusion of Segment by Application
Chapter 5 Hemophilia Gene Therapy Market Segment Analysis by Sales Channel
    5.1 Global Hemophilia Gene Therapy Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Hemophilia Gene Therapy Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Hemophilia Gene Therapy by Sales Channel in 2018
    5.4 Conclusion of Segment by Sales Channel
Chapter 6 Hemophilia Gene Therapy Market Segment Analysis by Region
    6.1 Global Hemophilia Gene Therapy Market Size and CAGR by Region (2013-2028)
    6.2 Global Hemophilia Gene Therapy Sales and Market Share by Region (2013-2018)
    6.3 Global Hemophilia Gene Therapy Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Hemophilia Gene Therapy Market Share by Type
        6.4.3 North America Hemophilia Gene Therapy Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Hemophilia Gene Therapy Market Share by Type
        6.5.3 Europe Hemophilia Gene Therapy Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Hemophilia Gene Therapy Market Share by Type
        6.6.3 Asia-Pacific Hemophilia Gene Therapy Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Hemophilia Gene Therapy Market Share by Type
        6.7.3 South America Hemophilia Gene Therapy Market Share by Application
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Hemophilia Gene Therapy Market Share by Type
        6.8.3 Middle East & Africa Hemophilia Gene Therapy Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Hemophilia Gene Therapy Players
    7.1 Spark Therapeutics
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Ultragenyx
    7.3 Shire PLC
    7.4 Sangamo Therapeutics
    7.5 Bioverativ
    7.6 BioMarin
    7.7 uniQure
    7.8 Freeline Therapeutics
Chapter 8 Upstream and Downstream Analysis of Hemophilia Gene Therapy
    8.1 Industrial Chain of Hemophilia Gene Therapy
    8.2 Upstream of Hemophilia Gene Therapy
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Hemophilia Gene Therapy
        8.3.1 Leading Distributors/Dealers of Hemophilia Gene Therapy
        8.3.2 Leading Consumers of Hemophilia Gene Therapy
Chapter 9 Development Trend of Hemophilia Gene Therapy (2019-2028)
    9.1 Global Hemophilia Gene Therapy Market Size (Sales and Revenue) Forecast (2019-2028)
    9.2 Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Region (2019-2028)
    9.3 Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Type (2019-2028)
    9.4 Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Application (2019-2028)
    9.5 Global Hemophilia Gene Therapy Market Size Forecast by Sales Channel (2019-2028)
Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification

Sidebar Menu